Transmedics Group Inc $TMDX

Recent News (7)

• Rosen Law Firm Announces Investigation of Breaches of Fiduciary Duties by the Directors and Officers of TransMedics Group, Inc. - TMDX PR Newswire · 01 Sep 2026 NEW YORK, Aug. 31, 2026 /PRNewswire/ -- Rosen Law Firm, a global investor rights law firm, continues to investigate potential breaches of fiduciary duties by the directors and officers of TransMedics …
• TransMedics to Present at Upcoming September Investor Conferences PR Newswire · 31 Aug 2026 ANDOVER, Mass., Aug. 31, 2026 /PRNewswire/ -- TransMedics Group, Inc. ("TransMedics") (Nasdaq: TMDX), a medical technology company that is transforming organ transplant therapy for patients with end-s…
• TransMedics Group Investigation Initiated: Kahn Swick & Foti, LLC Investigates the Officers and Directors of TransMedics Group, Inc. - TMDX PR Newswire · 29 Aug 2026 NEW YORK and NEW ORLEANS, Aug. 28, 2026 /PRNewswire/ -- Former Attorney General of Louisiana, Charles C. Foti, Jr., Esq., a partner at the law firm of Kahn Swick & Foti, LLC ("KSF"), announces that KS…
• Did TransMedics Group, Inc. Insiders Breach their Fiduciary Duties to Shareholders? PR Newswire · 25 Aug 2026 Shareholders are encouraged to contact the firm to discuss their rights and options at no cost or obligation. We would handle any matter on a contingent fee basis, whereby you would not be responsible…
• TransMedics to Present at the Canaccord Genuity 46th Annual Growth Conference PR Newswire · 28 Jul 2026 ANDOVER, Mass., July 28, 2026 /PRNewswire/ -- TransMedics Group, Inc. ("TransMedics") (Nasdaq: TMDX), a medical technology company that is transforming organ transplant therapy for patients with end-s…
• Did TransMedics Group, Inc. Insiders Breach their Fiduciary Duties to Shareholders? PR Newswire · 24 Jul 2026 Shareholders are encouraged to contact the firm to discuss their rights and options at no cost or obligation. We would handle any matter on a contingent fee basis, whereby you would not be responsible…
• TransMedics to Report Second Quarter 2026 Financial Results on August 4, 2026 PR Newswire · 21 Jul 2026 ANDOVER, Mass., July 21, 2026 /PRNewswire/ -- TransMedics Group, Inc. ("TransMedics") (Nasdaq: TMDX), a medical technology company that is transforming organ transplant therapy for patients with end-s…